As of 2025-12-28, the Relative Valuation of Nuvo Pharmaceuticals Inc (MRV.TO) is 2.53 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.35 CAD, the upside of Nuvo Pharmaceuticals Inc based on Relative Valuation is 87.3%.
The range of the Relative Valuation is 2.29 - 22.70 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.7x - 4.7x | 1.9x |
| Forward P/E multiples | 1.7x - 17.1x | 1.9x |
| Fair Price | 2.29 - 22.70 | 2.53 |
| Upside | 69.5% - 1581.5% | 87.3% |
| Date | P/E |